Metastatic Eccrine Porocarcinoma: A 5.6-Year Follow-up Study of a Patient Treated with a Combined Therapeutic Protocol

Dermatologic Surgery

Volumn 29, Issue 12, 2003, Pages 1227-1232

  González López, Marcos A ^a,b   Vázquez López, Francisco ^a   Soler, Tomás ^a   Gómez Díez, Santiago ^a   Hidalgo Garcia, Yolanda ^a   Manjón, Jose A ^a   López Escobar, María ^a   Pérez Oliva, Narciso ^a  

^a UNIVERSITY OF OVIEDO   (Spain)

^b NONE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ISOTRETINOIN; TEGAFUR;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER SURGERY; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; ECCRINE POROCARCINOMA; FOLLOW UP; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MALE; MULTIMODALITY CANCER THERAPY; PRIORITY JOURNAL; SIDE EFFECT; SKIN SURGERY; STANDARDIZATION; SWEAT GLAND CARCINOMA; TREATMENT OUTCOME;

ACROSPIROMA, ECCRINE; AGED; COMBINED MODALITY THERAPY; FOLLOW-UP STUDIES; HUMANS; MALE; NEOPLASM METASTASIS; SWEAT GLAND NEOPLASMS; TIME FACTORS;

EID: 17944399968     PISSN: 10760512     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1524-4725.2003.29393.x     Document Type: Article

References (34)

1. Wick MR, Goellner JR, Wolfe JT III, Daniel Su WP. Adnexal carcinomas of the skin: I: eccrine carcinomas. Cancer 1985;56:1147-62.
2. Santa Cruz DJ. Sweat gland carcinomas: a comprehensive review. Semin Diag Pathol 1987;4:38-74.
3. Mehregan AH, Hashimoto K, Rahbari H. Eccrine adenocarcinoma: a clinicopathologic study of 35 cases. Arch Dermatol 1983;119:104-14.
4. Urso C, Bondi R, Paglierani M, et al. Carcinomas of sweat glands: report of 60 cases. Arch Pathol Lab Med 2001;125:498-505.
5. Pinkus H, Mehregan AH. Epidermotropic eccrine carcinoma: a case combining features of eccrine poroma and Paget's dermatosis. Arch Dermatol 1963;88:597-606.
6. Mishima Y, Morioka S. Oncogenic differentiation of the intraepidermal eccrine sweat duct: eccrine poroma, poroepithelioma and porocarcinoma. Dermatologica 1969;138:238-50.
7. Shaw M, Mckee PH, Lowe D, Black MM. Malignant eccrine poroma: a study of twenty-seven cases. Br J Dermatol 1982;107:675-80.
8. Poiares-Baptista A, Tellechea O, Reis JP, Cunha MF, Figueiredo P. Porocarcinoma eccrine: a review of 24 cases. Ann Dermatol Venereol 1993;120:107-15.
9. Robson A, Greene J, Ansari N, et al. Eccrine porocarcinoma (malignant eccrine poroma): a clinicopathological study of 69 cases. Am J Surg Pathol 2001;25:710-20.
10. Perna C, Cuevas J, Jiménez-Heffernan JA, Hardisson D, Contreras F. Eccrine porocarcinoma (malignant eccrine poroma). Am J Surg Pathol 2002;26:272-3.
11. Snow SN, Reizner GT. Eccrine porocarcinoma of the face. J Am Acad Dermatol 1992;27:306-11.
12. Lozano Orella JA, Valcayo Peñalba A, San Juan CC, et al. Eccrine porocarcinoma: report of nine cases. Dermatol Surg 1997;23:925-8.
13. Wittenberg GP, Robertson DB, Solomon AR, Washintong CV. Eccrine porocarcinoma treated with Mohs micrographic surgery: a report of five cases. Dermatol Surg 1999;25:911-3.
14. Grosshans E, Vetter JM, Capesius C. Poromes eccrines malins. Ann Anat Pathol 1975;20:381-94.
15. Kolde G, Macher E, Grundmann E. Metastasizing eccrine porocarcinoma: report of two cases with fatal outcome. Path Res Pract 1991;187:477-81.
16. Landa NG, Winkelmann RK. Epidermotropic eccrine porocarcinoma. J Am Acad Dermatol 1991;24:27-31.
17. Huet P, Dandurand M, Pignodel C, Guillot B. Metastasizing eccrine porocarcinoma: report of a case and review of the literature. J Am Acad Dermatol 1996;35:860-4.
18. Barzi AS, Ruggeri S, Recchia F, Bertoldi I. Malignant metastatic eccrine poroma: proposal for a new therapeutic protocol. Dermatol Surg 1997;23:267-72.
19. Grimme H, Petres A, Bergen E, et al. Metastasizing porocarcinoma of the head with lethal outcome. Dermatology 1999;198:298-300.
20. Plunkett TA, Hanby AM, Miles DW, Rubens RD. Metastatic eccrine porocarcinoma: response to docetaxel (Taxotere) chemotherapy. Ann Oncol 2001;12:411-4.
21. Pernal S, Chemal N, Dhote R, Palangie A, Christoforov B. Métastases pulmonaires révélatrices d'une tumeur cutanée rare: le porocarcinome eccrine. Rev Med Interne 2000;21:91-4.
22. Requena L, Sanchez M, Aguilar A, Ambrojo P, Sanchez Yus E. Periungual porocarcinoma. Dermatologica 1990;180:177-80.
23. Katsanis WA, Doering DL, Bosscher JR, O'Connor DM. Vulvar eccrine porocarcinoma. Gynecol Oncol 1996;62:396-9.
24. McMichael AJ, Gay J. Malignant eccrine poroma in an elderly African-American woman. Dermatol Surg 1999;25:733-5.
25. El-Domeiri AA, Brasfield RD, Huvos AG, Strong EW. Sweat gland carcinoma: a clinico-pathological study of 83 patients. Ann Surg 1971;173:270-4.
26. Harari PM, Shimm DS, Bangert JL, Cassady JR. The role of radiotherapy in the treatment of malignant sweat gland neoplasms. Cancer 1990;65:1737-40.
27. Whittington R, Browning ME, Farrel GR, Miremadi A. Radiation therapy and chemotherapy in malignant sweat gland tumors. J Am Acad Dermatol 1986;15:1093-7.
28. Yamamoto O, Haratake J, Yokoyama S, Imayama S, Asahi M. A histopathological and ultrastructural study of eccrine porocarcinoma with special reference to its subtypes. Virchows Arch A Pathol Anat 1992;420:395-401.
29. Roach M. A malignant eccrine poroma responds to isotretinoin (13-cis-retinoic acid). Ann Intern Med 1983;99:486-8.
30. Briscoe KE, Grage T, Kennedy BJ. Sustained complete remission of metastatic sweat gland carcinoma following regional hyperthermic perfusion. JAMA 1978;240:51-2.
31. Swanson JD, Pazdur R, Sykes E. Metastatic sweat gland carcinoma: response to 5-fluorouracil infusion. J Surg Oncol 1989;42:69-72.
32. Dummer R, Becker JC, Boser B, Hartmann AA, Burg G. Successful therapy of metastatic eccrine poroma using perilesional interferon alfa and interleukin 2. Arch Dermatol 1992;128:1127-8.
33. Sun W, Haller D. UFT in the treatment of colorectal and breast cancer. Oncology 2001;15(16 Suppl 2):49-56.
34. Andersen E, Pedersen H. Oral ftorafur versus intravenous 5-fluorouracil: a comparative study in patients with colorectal cancer. Acta Oncol 1987;26:433-6.